View Item 

Show simple item record

Synthetic immunoregulating molecules: A potential bridge between cytostatic chemotherapy and immunotherapy of cancer

dc.contributor.authorJohnson, Arthur G.en_US
dc.contributor.authorAudibert, Françoiseen_US
dc.contributor.authorChedid, Louisen_US
dc.date.accessioned2006-09-11T18:17:15Z
dc.date.available2006-09-11T18:17:15Z
dc.date.issued1978-04en_US
dc.identifier.citationJohnson, Arthur G.; Audibert, Françoise; Chedid, Louis; (1978). "Synthetic immunoregulating molecules: A potential bridge between cytostatic chemotherapy and immunotherapy of cancer." Cancer Immunology Immunotherapy 3(4): 219-227. <http://hdl.handle.net/2027.42/46856>en_US
dc.identifier.issn0340-7004en_US
dc.identifier.issn1432-0851en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/46856
dc.format.extent1000868 bytes
dc.format.extent3115 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.language.isoen_US
dc.publisherSpringer-Verlagen_US
dc.subject.otherBiomedicineen_US
dc.subject.otherImmunologyen_US
dc.subject.otherCancer Researchen_US
dc.subject.otherOncologyen_US
dc.titleSynthetic immunoregulating molecules: A potential bridge between cytostatic chemotherapy and immunotherapy of canceren_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelMicrobiology and Immunologyen_US
dc.subject.hlbsecondlevelBiological Chemistryen_US
dc.subject.hlbtoplevelScienceen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Microbiology, University of Michigan, 6643 Med. Science Bdg II, 48104, Ann Arbor, Michigan, USAen_US
dc.contributor.affiliationotherGroupe de Recherche no 31 du C.N.R.S., Immunothérapie Expérimentale, Institut Pasteur, 28 rue du Dr. Roux, F-75724, Paris cedex 15, Franceen_US
dc.contributor.affiliationotherGroupe de Recherche no 31 du C.N.R.S., Immunothérapie Expérimentale, Institut Pasteur, 28 rue du Dr. Roux, F-75724, Paris cedex 15, France; INSERM, Parisen_US
dc.contributor.affiliationumcampusAnn Arboren_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/46856/1/262_2004_Article_BF00200075.pdfen_US
dc.identifier.doihttp://dx.doi.org/10.1007/BF00200075en_US
dc.identifier.sourceCancer Immunology Immunotherapyen_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
262_2004_Article_BF00200075.pdf
Size:
977.4KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.